D.E. Shaw & Co’s Pulse Biosciences PLSE Stock Holding History

D.E. Shaw & Co’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$296K	Buy	+13,726	New	+$253K	﹤0.01%	4077
2022 Q3	–	Sell	-31,827	Closed	-$49K	–	5448
2022 Q2	$49K	Sell	31,827 -69,189	-68%	-$174K	﹤0.01%	4845
2022 Q1	$491K	Buy	+101,016	New	+$827K	﹤0.01%	4379
2021 Q3	–	Sell	-17,528	Closed	-$287K	–	5161
2021 Q2	$287K	Buy	+17,528	New	+$334K	﹤0.01%	4304
2021 Q1	–	Sell	-12,391	Closed	-$296K	–	4397
2020 Q4	$296K	Buy	+12,391	New	+$197K	﹤0.01%	3605

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co's PLSE Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 13,726 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #4077 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in PLSE as recently as Q2 2022.

D.E. Shaw & Co first reported a position in PLSE in Q4 2020 and has held it in 5 quarters since. The position peaked at $491K in Q1 2022. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

D.E. Shaw & Co held 13,726 shares of Pulse Biosciences worth $296K as of Q1 2026.
Pulse Biosciences was a new D.E. Shaw & Co position in Q1 2026.
Pulse Biosciences made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4077 holding.
D.E. Shaw & Co first reported a position in Pulse Biosciences in Q4 2020 and has held it in 5 quarters since.
D.E. Shaw & Co's Pulse Biosciences position peaked at $491K in Q1 2022.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.